Advertisement

Requests for Imaging Using Contrast Media: What Information Must be Provided

  • Sameh K. Morcos
  • Marie-France Bellin
Part of the Medical Radiology book series (MEDRAD)

Abstract

A questionnaire is proposed for any imaging examination requiring contrast agent administration. Information about important risk factors is essential and drug history is also important because of possible interactions between contrast agents and other drugs. This information should be available before the appointment, so that prophylactic measures can be planned or an alternative imaging technique not requiring contrast agent administration can be advised.

Keywords

Contrast Agent Iodine Deficiency Multinodular Goiter Nephrogenic Systemic Fibrosis Contrast Agent Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bellin MF, Webb JAW, van der Molen A, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Safety of MR liver specific contrast media. Eur Radiol 15:1607–1614PubMedCrossRefGoogle Scholar
  2. Bostom AG, Kronenberg F, Ritz E (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 13:2140–2144PubMedCrossRefGoogle Scholar
  3. Briguori C, Colombo A, Airoldi F et al (2006) Gadolinium-based contrast agent and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 67:175–180PubMedCrossRefGoogle Scholar
  4. Ergün I, Keven K, Uruf I et al (2006) The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 21:697–700PubMedCrossRefGoogle Scholar
  5. McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 103:368–375PubMedCrossRefGoogle Scholar
  6. Morcos SK (2004) Prevention of contrast media nephrotoxicity—the story so far. Clin Radiol 59:381–389PubMedCrossRefGoogle Scholar
  7. Morcos SK (2005a) Acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 78:686–693PubMedCrossRefGoogle Scholar
  8. Morcos SK (2005b) Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol 16:13–23PubMedCrossRefGoogle Scholar
  9. Morcos SK, Thomsen HS (2001) Adverse reactions to iodinated contrast media. Eur Radiol 11:1267–1275PubMedCrossRefGoogle Scholar
  10. Morcos SK, Thomsen HS, Webb JAW, Members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (1999) Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613Google Scholar
  11. Morcos SK, Thomsen HS, Webb JAW, Members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2001) Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 11:1720–1728Google Scholar
  12. Morcos SK, Thomsen HS, Exley CM, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Contrast media: interaction with other drugs and clinical tests. Eur Radiol 15:1463–1468Google Scholar
  13. Niendorf HP, Alhassan A, Haustein J et al (1993) Safety and risk of gadolinium-DTPA: extended clinical experience after more than 5,000,000 applications. Adv MRI Contrast 2:12–19Google Scholar
  14. Sam AD, Morash MD, Collins J et al (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313–318PubMedCrossRefGoogle Scholar
  15. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484PubMedCrossRefGoogle Scholar
  16. Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14:1654–1656PubMedGoogle Scholar
  17. Thomsen HS (ed) (2006) Contrast media: safety issues and ESUR guidelines. Springer, HeidelbergGoogle Scholar
  18. Thomsen HS, Almen T, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600–2605Google Scholar
  19. Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) In which patients should serum-creatinine be measured before contrast medium administration? Eur Radiol 15:749–754Google Scholar
  20. Webb JAW, Stacul F, Thomsen HS, Morcos SK, Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2003) Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184Google Scholar
  21. Zhang HL, Ersoy H, Prince MR (2006) Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements. J Magn Reson Imaging 23:383–387PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Diagnostic ImagingUniversity of SheffieldSheffieldUK
  2. 2.Service de Radiologie Générale Adultes, Hôpital de Bicêtre, Secteur Paul BrocaLe Kremlin-Bicêtre CedexFrance

Personalised recommendations